Matches in Ubergraph for { <https://frink.apps.renci.org/.well-known/genid/B71353fb574e0fe8c647c13e8be58b1a6> ?p ?o ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- B71353fb574e0fe8c647c13e8be58b1a6 NCIT_P378 "NCI" @default.
- B71353fb574e0fe8c647c13e8be58b1a6 type Axiom @default.
- B71353fb574e0fe8c647c13e8be58b1a6 annotatedProperty IAO_0000115 @default.
- B71353fb574e0fe8c647c13e8be58b1a6 annotatedSource NCIT_C129546 @default.
- B71353fb574e0fe8c647c13e8be58b1a6 annotatedTarget "An orally bioavailable inhibitor of the splicing factor 3B subunit 1 (SF3B1), with potential antineoplastic activity. Upon administration, H3B-8800 binds to and blocks the activity of SF3B1, a core spliceosome protein that is mutated in various cancer cells. This modulates RNA splicing by preventing aberrant mRNA splicing by the spliceosome, blocks RNA mis-splicing, enhances proper RNA splicing and prevents the expression of certain tumor-associated genes. This leads to an induction of apoptosis and prevents tumor cell proliferation. In many cancer cells, core spliceosome proteins, including SF3B1, U2 small nuclear ribonucleoprotein auxiliary factor 1 (U2AF1), serine/arginine-rich splicing factor 2 (SRSF2) and U2 small nuclear ribonucleoprotein auxiliary factor subunit-related protein 2 (ZRSR2), are mutated and aberrantly activated leading to a dysregulation of mRNA splicing." @default.